Medeon Biodesign Past Earnings Performance

Past criteria checks 0/6

Medeon Biodesign's earnings have been declining at an average annual rate of -38.9%, while the Medical Equipment industry saw earnings growing at 11.4% annually. Revenues have been declining at an average rate of 21.5% per year.

Key information

-38.9%

Earnings growth rate

-38.6%

EPS growth rate

Medical Equipment Industry Growth11.5%
Revenue growth rate-21.5%
Return on equity-53.6%
Net Margin-613.8%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Medeon Biodesign's (GTSM:6499) Stock Price Has Reduced 71% In The Past Five Years

Feb 09
Medeon Biodesign's (GTSM:6499) Stock Price Has Reduced 71% In The Past Five Years

Revenue & Expenses Breakdown
Beta

How Medeon Biodesign makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:6499 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23196-1,205186667
30 Sep 23178-1,185199631
30 Jun 23173-1,115185612
31 Mar 23151-675179567
31 Dec 22298-434153522
30 Sep 22271-356125500
30 Jun 22240-410115460
31 Mar 22249-357109441
31 Dec 2169-540108416
30 Sep 21142-488105372
30 Jun 21141-426102336
31 Mar 21117-38997306
31 Dec 20123-37198290
30 Sep 20162-399114294
30 Jun 20279-351132300
31 Mar 20377-306140307
31 Dec 19454-262143301
30 Sep 19412-221130272
30 Jun 19350-200112240
31 Mar 19300-169106201
31 Dec 18674257107197
30 Sep 18639222108216
30 Jun 18604215109214
31 Mar 18596181109229
31 Dec 17165-248103216
30 Sep 17148-24097206
30 Jun 17120-24089199
31 Mar 1766-22578178
31 Dec 1629-21971163
30 Sep 160-20463154
30 Jun 160-18458150
31 Mar 160-17353149
31 Dec 150-14847135
30 Sep 150-11638110
30 Jun 150-1053296
31 Mar 150-842875
31 Dec 140-732465
30 Sep 140-572451
30 Jun 140-412537
31 Mar 140-372331

Quality Earnings: 6499 is currently unprofitable.

Growing Profit Margin: 6499 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 6499 is unprofitable, and losses have increased over the past 5 years at a rate of 38.9% per year.

Accelerating Growth: Unable to compare 6499's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 6499 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-17.2%).


Return on Equity

High ROE: 6499 has a negative Return on Equity (-53.55%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.